Centrum silver and Urinary retention - a phase IV clinical study of FDA data

Summary:

Urinary retention is reported as a side effect among people who take Centrum silver (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e), especially for people who are female, 60+ old, have been taking the drug for 10+ years also take Oxycontin, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Urinary retention when taking Centrum silver. It is created by eHealthMe based on reports of 19,412 people who have side effects when taking Centrum silver from the FDA, and is updated regularly.

What is Centrum silver?

Centrum silver has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. It is often used in vitamin supplementation. eHealthMe is studying from 19,997 Centrum silver users. Check the latest studies of Centrum silver.

What is Urinary retention?

Urinary retention (the inability to completely or partially empty the bladder) is found to be associated with 1,569 drugs and 1,739 conditions by eHealthMe. Check the latest studies of Urinary retention.

On Jul, 29, 2026

19,412 people reported to have side effects when taking Centrum silver.
Among them, 95 people (0.49%) have Urinary retention.

Could Centrum silver cause Urinary retention?

Among these 95 people:

How long have people been on Centrum silver when they have Urinary retention? *

What is the gender of people who have Urinary retention when taking Centrum silver? *

female: 56.04 %
male: 43.96 %

What is the age of people who have Urinary retention when taking Centrum silver? *

What are other drugs people take besides Centrum silver? *

What are other side effects people have besides Urinary retention? *

Urinary Tract Infection: 46 people, 48.42%
Pain: 40 people, 42.11%
Joint Pain: 39 people, 41.05%
Weakness: 37 people, 38.95%
Fall: 36 people, 37.89%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 34 people, 35.79%
Osteonecrosis Of Jaw (death of bone of jaw): 33 people, 34.74%
Bone Disorder: 33 people, 34.74%
Pain In Extremity: 33 people, 34.74%
Dyspnea (difficult or laboured breathing): 33 people, 34.74%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 12 people, 12.63%
Metastases To Bone (cancer spreads to bone): 9 people, 9.47%
Breast Cancer: 8 people, 8.42%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 6 people, 6.32%
High Blood Pressure: 6 people, 6.32%
High Blood Cholesterol: 6 people, 6.32%
Lung Cancer - Non-Small Cell (lung cancer): 5 people, 5.26%
Prostate Cancer: 5 people, 5.26%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 4.21%
Pain: 4 people, 4.21%

* Approximation only. Some reports may have incomplete information.

Do you take Centrum silver and have Urinary retention?

- Check whether Urinary retention is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Centrum silver:

Centrum silver (19,997 reports)

Urinary retention treatments and more:

Urinary retention (42,974 reports)

How severe was Urinary retention and when was it recovered:

Urinary retention in Centrum silver

Expand to all the drugs that have ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e:

Urinary retention and drugs with ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e (852 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Centrum silver:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary retention:

Urinary retention (1,569 drugs)

Browse all the conditions that are associated with Urinary retention:

Urinary retention (1,739 conditions)

Related publications that referenced our studies

Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .

How the study uses the data?

The study uses data from the FDA. It is based on ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e (the active ingredients of Centrum silver) and Centrum silver (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.